State UT
Clinical Trials in Utah
Recruiting clinical trials with at least one study location in Utah. Data updated daily from ClinicalTrials.gov.
Top Conditions in Utah
NCT04323046 Phase 1
Recruiting
Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive...
Condition
Glioblastoma
Enrollment
20 pts
Location
United States, Australia
Sponsor
Sabine Mueller, MD, PhD
NCT05498428 Phase 2
Recruiting
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors ...
Condition
Carcinoma, Non-small-Cell Lung
Enrollment
520 pts
Location
United States, Brazil, China
Sponsor
Janssen Research & Development
NCT03556228 Phase 1, Phase 2
Recruiting
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpr...
Condition
Head and Neck Carcinoma
Enrollment
242 pts
Location
United States, Puerto Rico
Sponsor
VM Oncology, LLC
NCT06258109 N/A
Recruiting
Risk of Recurrent CeAD After Pregnancy
Condition
Cervical Artery Dissection
Enrollment
1,000 pts
Location
United States, Argentina, Austria
Sponsor
University Hospital, Basel, Sw
NCT06964464 Phase 4
Recruiting
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Fai...
Condition
Heart Failure With Reduced Ejection Fraction (HFrEF)
Enrollment
2,000 pts
Location
United States
Sponsor
University of Rochester
NCT06932887 Phase 3
Recruiting
The Beat Pain Better Trial
Condition
Osteoarthritis
Enrollment
346 pts
Location
United States
Sponsor
University of Utah
NCT05267821 Phase 2, Phase 3
Recruiting
Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS
Condition
Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS)
Enrollment
500 pts
Location
United States
Sponsor
Nationwide Children's Hospital
NCT06321302 Phase 2
Recruiting
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diab...
Condition
Diabetic Retinopathy
Enrollment
178 pts
Location
United States, Germany, Hungary
Sponsor
Boehringer Ingelheim
NCT06056830 Phase 3
Recruiting
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-ri...
Condition
Prostate Cancer
Enrollment
383 pts
Location
United States, Australia
Sponsor
Clarity Pharmaceuticals Ltd
NCT07382167 Phase 3
Recruiting
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopa...
Condition
Chronic Idiopathic Constipation (CIC)
Enrollment
692 pts
Location
United States
Sponsor
Ardelyx
NCT05304065 Phase 2
Recruiting
Safe Treatment for Emergency Presentation for Suicidal Ideation and Behavior in ...
Condition
Suicide
Enrollment
1,600 pts
Location
United States
Sponsor
University of California, Los
NCT07223047 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone a...
Condition
Advanced Solid Malignancies
Enrollment
252 pts
Location
United States, Canada, Spain
Sponsor
Bristol-Myers Squibb
Page 7 of 7 — 162 trials total